


p16 INK4A Antibody (DCS-50) is a mouse monoclonal IgG1 antibody that detects p16 INK4A in human samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA). p16 INK4A plays a crucial role as a tumor suppressor by inhibiting cyclin-dependent kinase 4 (Cdk4), thereby preventing the phosphorylation of the retinoblastoma protein (Rb) and blocking cell cycle progression from the G1 phase to the S phase. This function is vital for maintaining proper cell cycle regulation and preventing uncontrolled cell proliferation, which is a hallmark of cancer. Notably, the gene encoding p16 INK4A is frequently altered in various human tumors, with homozygous deletions and point mutations being common, underscoring p16 INK4A′s importance in cancer biology. Anti-p16 INK4A antibody (DCS-50) is an essential tool for researchers studying cell cycle regulation and the molecular mechanisms underlying tumorigenesis, providing insights into potential therapeutic targets for cancer treatment.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CDKN2A/p16 Antibody (DCS-50) | sc-65476 | 200 µg/ml | $322.00 | |||
CDKN2A/p16INK4a Antibody (DCS-50): m-IgG Fc BP-HRP Bundle | sc-539174 | 200 µg Ab; 10 µg BP | $361.00 | |||
CDKN2A/p16INK4a Antibody (DCS-50): m-IgG1 BP-HRP Bundle | sc-541310 | 200 µg Ab; 20 µg BP | $361.00 |